Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study

Conditions:   Adenocarcinoma - GEJ;   Gastric Adenocarcinoma Intervention:   Drug: Dostarlimab Sponsor:   GERCOR - Multidisciplinary Oncology Cooperative Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials